Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Oncogene|April 15, 2008
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer modelsD Li, L Ambrogio, T Shimamura, et al.
ESMO Open|January 18, 2025
Molecular characterization of HER2-negative breast cancers reveals a distinct patient subgroup with 17q12 deletion and heterozygous loss of ERBB2X Qiu, P Tarantino, R Li, et al.
British Journal of Cancer|July 3, 2008
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patientsJ P Koivunen, J Kim, J Lee, et al.
Oncogene|February 22, 2007
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272Y Minami, T Shimamura, K Shah, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclassesA Bhattacharjee, W G Richards, J Staunton, et al.
Cancer Research|December 4, 2001
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individualsR H Vonderheide, J L Schultze, K S Anderson, et al.
Oncogene|June 10, 2014
Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequencesT J Pugh, W Yu, J Yang, et al.
Gynecologic Oncology|July 5, 2014
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterationsE Wik, J Trovik, K Kusonmano, et al.
Gastrointestinal Endoscopy|February 28, 2002
"Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary strictureMarc F Catalano, Joseph E Geenen, Glen A Lehman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2009
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationH B Salvesen, S L Carter, M Mannelqvist, et al.
Pageof 8